More than 9 million people take a prescribed medicine daily, with 8 million taking two or more prescribed medicines a week, according to a new survey.
Common chemicals are causing many Australians to develop debilitating sensitivities.
The MATOS PLUS range of refrigerators features an aluminium interior and the latest technology in controllers and compressors for accurate temperature stability.
A new study has found that some vitamin and mineral supplements may be detrimental, rather than beneficial, to your health.
In line with international trends, the Advancing of Australian Pharmacy Practice credential provides a pathway to improved outcomes for patients.
Now available on the PBS, BRIVIACT (brivaracetam) is an add-on therapy for the treatment of partial-onset seizures (POS).
Low-level lead exposure may be responsible for around 30% of premature deaths from cardiovascular disease in the USA each year.
Hospital pharmacists are committed to supporting sustainability.
Fentanyl — alone, or in combination with stimulants — may put substance users at further risk, whether they take it knowingly or not, by causing amnesia.
The product is approved for the treatment of schizophrenia and bipolar I disorder, as well as for use as an add-on treatment for depression in adults.
October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.
The Pharmaceutical Benefit Scheme (PBS) medicines in hospitals program enables hospital access to PBS funding in some capacity in most states and territories. Adoption by NSW and the ACT would cement this landmark program.
A cure to diabetes is one step closer, with scientists exploring insulin-secreting skin cells.
A urine test may offer more definitive evidence of GHB, supporting law enforcement.
Researchers testing medical marijuana on epilepsy have found it can adversely interact with antiepileptic drugs.